Advertisement
Screener

GAIN THERAPEUTICS, INC (GANX) Stock Issued During Period, Value, Stock Options Exercised

GAIN THERAPEUTICS, INC Stock Issued During Period, Value, Stock Options Exercised

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • GAIN THERAPEUTICS, INC stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $0.00.
  • GAIN THERAPEUTICS, INC stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $0.00.
  • GAIN THERAPEUTICS, INC stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $57.71K.
  • GAIN THERAPEUTICS, INC stock issued during period, value, stock options exercised for fiscal 2025 was $250.26K.
  • GAIN THERAPEUTICS, INC stock issued during period, value, stock options exercised for fiscal 2021 was $12.22K.
Period endStock Issued During Period, Value, Stock Options Exercised 3 monthStock Issued During Period, Value, Stock Options Exercised 12 month
2025-12-31$250.26K
10-K · filed 2026-03-26
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
2024-03-31$57.71K
10-Q · filed 2025-05-14
2021-12-31$12.22K
10-K · filed 2023-03-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B